Select country change
Shopping cart (0 , 0,00 ) Menu Search

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
  • References to Proteinase 3 (PR3) Human ELISA

    • Korkmaz, B., Moreau, T. & Gauthier, F. Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical properties, activity and physiopathological functions. Biochimie 90, 227-242 (2008).
    • Mihara, K., Ramachandran, R., Renaux, B., Saifeddine, M. & Hollenberg, M.D. Neutrophil elastase and proteinase-3 trigger G-protein biased signaling through proteinase activated receptor-1 (PAR1). J Biol Chem (2013).
    • Nauseef, W.M. & Borregaard, N. Neutrophils at work. Nature immunology 15, 602-611 (2014).
    • Ng, L.L., et al. Proteinase 3 and prognosis of patients with acute myocardial infarction. Clinical science 120, 231-238 (2011).
    • Pham, C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6, 541-550 (2006).
    • van der Geld, Y.M., Limburg, P.C. & Kallenberg, C.G. Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol 69, 177-190 (2001).
    • Wiedow, O. & Meyer-Hoffert, U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 257, 319-328 (2005).
    • Wang, Y., et al. Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated with beta-cell Autoimmunity in Patients with Type 1 Diabetes. Diabetes (2014).
  • References to Proteinase 3 (PR3) Mouse ELISA

    • Korkmaz, B., Moreau, T. & Gauthier, F. Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical properties, activity and physiopathological functions. Biochimie 90, 227-242 (2008).
    • Mihara, K., Ramachandran, R., Renaux, B., Saifeddine, M. & Hollenberg, M.D. Neutrophil elastase and proteinase-3 trigger G-protein biased signaling through proteinase activated receptor-1 (PAR1). J Biol Chem (2013).
    • Nauseef, W.M. & Borregaard, N. Neutrophils at work. Nature immunology 15, 602-611 (2014).
    • Ng, L.L., et al. Proteinase 3 and prognosis of patients with acute myocardial infarction. Clinical science 120, 231-238 (2011).
    • Pham, C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6, 541-550 (2006).
    • van der Geld, Y.M., Limburg, P.C. & Kallenberg, C.G. Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol 69, 177-190 (2001).
    • Wang, Y., et al. Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated with beta-cell Autoimmunity in Patients with Type 1 Diabetes. Diabetes (2014).
    • Wiedow, O. & Meyer-Hoffert, U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 257, 319-328 (2005).
  • References to Prouroguanylin Human ELISA

    • Kaar G, Dieplinger B, Gabriel C, Haltmayer M, Mueller T. Proguanylin and prouroguanylin--assay evaluation and clinical analyte characterization. Clin Chim Acta. 2011 Nov 20;412(23-24):2277-83. doi: 10.1016/j.cca.2011.08.016. Epub 2011 Aug 24.
  • References to PYY Human ELISA

    • Adrian, T.E., Smith, H.A., Calvert, S.A., Aynsley-Green, A. and Bloom, S.R. (1986): Elevated plasma peptide YY in human neonates and infants. Pediatr Res.,20:1225-1227.
    • Adrian T.E., Ferri, G.L., Bacarese-Hamilton, A.J., Fuessl, H.S., Polak, J.M. and Bloom, S.R.(1995): Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology, 89: 1070-1077.
    • El-Salhy, M., Grimelius, L., Wilander, E., Ryberg B., Terenius, L., Lundburg, J.M. and Tatemoto, K.(1983): Immunocytochemical identification of polypeptide YY(PYY) cells in the human gastrointestinal tract. Histochemistry, 77:15-23.
    • Greeley, G.H.Jr., Hashimoto, T., Izukura, M., Gomez, G., Jeng, J., Hill, F.L., Liuis, F.,and Thompson, J.C.(1989): A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide YY in the dog. Endocrinology, 125:1761-1765.
    • Greeley, G.H.Jr., Hill, F. L., Spannagel, A.and Thompson, J.C.(1987): Distribution of peptide YY in gastrointestinal tract of the rat, dog, and monkey. Regul.Pept., 19, 365-372.
    • Gomez, G., Zhang, T., Rajaraman, S., Thakore, K.N., Yanaihara, N., Townsend C.M.Jr., Thompson, J.C. and Greeley, G.H.Jr.(1995): Intestinal peptide YY : ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel. Am J.Physiol. 268, G71-G81.
    • Larhammar, D.(1996): Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide: Regul.Pept., 62, 1-11.
  • References to PYY Rat ELISA

    • Adrian, T.E., Smith, H.A, Calvert, S.A., Aynsley-Green, A. and Bloom, S.R.: Elevated plasma peptide YY in human neonates and infants. Pediatric Research, 20:1225 -1227. 1986
    • Adrian T.E., Ferri, G.L., Bacarese-Hamilton, A.J., Fuessl, H.S., Polak, J.M. and Bloom, S.R.: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology, 89:1070-1077. 1995
    • El-Salhy, M., Grimelius, L., Wilander, E ., Ryberg B., Terenius, L., Lundburg, J.M. and Tatemoto, K.: Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry, 77:15-23. 1983
    • Greeley, G.H. Jr., Hashimoto, T., Izukura, M., Gomez, G., Jeng, J. Hill, F.L.C., Liuis, F., and Thompson, J.C.: A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide YY in the dog. Endocrinology, 125:1761 -1765. 1989
    • Greeley, G.H. Jr., Hill, F. L. C., Spannagel, A. and Thompson, J.C.: Distribution of peptide YY in gastrointestinal tract of the rat dog, and monkey. Regulated Peptides, 19, 365-372. 1987 ¨- Gomez, G., Zhang, T., Rajaraman, S., Thakore, K.N., Yanaihara, N., Townsend C.M. Jr., Thompson, J.C. and Greeley, G.H. Jr.: Intestinal peptide YY : ontogeny of gene expression in rat bowel and trophic action on rat and mouse bowel. American Journal Physiology. 268, G71-G81. 1995
    • Larhammar, D.: Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide: Regulated Peptides, 62, 1-11. 1996
    • National Committee for Clinical Laboratory Standards Evaluation Protocols, SC1, (1989), Vallanova, PA: NCCLS